The lawsuit, filed in the U.S. District Court for the District of Delaware, alleges patent infringement related to Impax's filing of an Abbreviated New Drug Application for a generic version of Opana ER.

Impax is seeking to produce an oxymorphone hydrochloride extended-release tablets, a generic version of Opana ER. The morphine-like drug is a pain reliever typically prescribed for those who...